$ABEO News Article - Abeona Therapeutics Reinitiates Enrollment in EB-101 Pivotal Phase 3 VIITAL(TM) Study in RDEB after COVID-19 Related Pause and Announces Progress in Patient Enrollment in MPS III Studies
https://marketwirenews.com/news-releases/abeo...57851.html